Gonzalez-Naranjo P. Perez-Macias N. Campillo N.E. Pérez C. Arán V. J. Girón R Sanchez-Robles E. Martín MI, Gómez-Cañas M. Gracía-Arencibia M. Fernandez-Ruiz J. Cannabinoid agonists showingBuChE inhibition as potential therapeutic agents for Alzheimer´s disease, European ÇJ. Med Chem 73:56-72 (2014)

Fernández-Fernández C, Decara J, Bermúdez-Silva FJ, Sánchez R, Morales P, Gómez-Cañas M, Gómez-Ruíz M, Callado LF, Goya P, Rodríguez de Fonseca F, Martıín MI, Fernández-Ruíz J, Meana JJ, Jagerovic N, Archiv der Pharmazie. 346(3):171-9, (2013)

Abalo R, Cabezos PA, Vera G, López-Pérez AE, Martín-Fontelles MI. Cannabinoids may worsen gastric dysmotility induced by chronic cisplatin in the rat.: Neurogastroenterology and Motility. 25; 373 l: e292 (2013)

Vera G, Cabezos PA, Martín MI, Abalo R. Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy Pharmacology, Biochemistry & Behavior. 105C ; 205: 212 (2013)

Description of a Bivalent Cannabinoid Ligand with Hypophagic Properties. Archiv der Pharmazie 346(3); 171: 179 (2013)

Fernández-Fernández C, Decara J, Bermúdez-Silva FJ, Sánchez E, Morales P, Gómez-Cañas M, Gómez-Ruíz M, Callado LF, Goya P, Rodríguez de Fonseca F, Martín MI, Fernández-Ruíz J, Meana JJ, Jagerovic N.

Sánchez Robles E, Bagüés Arias A, Martín Fontelles MI. Cannabinoids and muscular pain. Effectiveness of the local administration in rat.: Eur J Pain. 16(8); 1116: 1127 (2012)

Abalo R, Vera G, López-Pérez AE, Martínez-Villaluenga M, Martín-Fontelles MI. The gastrointestinal pharmacology of cannabinoids: Focus on motility. Pharmacology. 90(1-2); 1: 10 (2012)

Vera G, López-Miranda V, Herradón E, Martín-Fontelles MI, Abalo R. Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes. Pharmacol, Biochem & Behav. 102(2); 335: 343 (2012)

Burgos E, Gómez-Nicola D, Pascual D, Martín MI, Nieto-Sampedro M, Goicoechea C. Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells. Eur J Pharmacol. 682(1-3); 62: 72 (2012)

Cumella J, Hernández-Folgado L, Girón R, Sánchez E, Morales P, Hurst DP, Gómez-Cañas M, Gómez M, Pinto D, Goya P, Reggio PH, Martín MI, Fernández-Ruiz J, Silva A, Jagerovic N. Chromenopyrazoles: non-psychoactive and selective CB1 cannabinoid agonists with peripheral antinociceptive properties. Chem Med Chem. 7(3); 452: 463 (2012)

Pérez-Fernández R, Fresno N, Macías-González M, Elguero J, Decara J, Girón R, Rodríguez-Álvarez A, Martín MI, Rodríguez de Fonseca F, Goya P. Discovery of potoent dual PPARa agonists/CB1 ligands.: ACS Med Chem Lett. 2; 793: 797 (2011)

González C, Herradón E, Abalo R, Vera G, Pérez-Nievas BG, Leza JC, Martín MI, López-Miranda V. Cannabinoid/agonist Win 55,212-2 reduces cardiac ischaemia-reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOs/eNOs. Diabetes Metab Res Revs. 27(4); 331: 340 (2011)

Abalo R, Cabezos P, Vera G, López-Miranda V, Herradón E, Martín-Fontelles MI. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat. Role of CB1 receptors. Neurogastroenterol Motil 23(5); 457: e177(2011)

Vera G, Castillo M, Cabezos P, Chiarlone A, Martín MI, Gori A, Pasquinelli G, Barbara G, Stanghellini V, Corinaldesi R, De Giorgio R, Abalo R. Enteric neuropathy evoked by repeated cisplatin in the rat.. Neurogastroenterol Motil. 23(4); 370: e163 (2011)

López-Miranda V, Dannert MT, Herradón E, Alsasua A, Martín MI. Cytochrome P450 Pathway Contributes to Methanandamide-induced Vasorelaxation in Rat Aorta. Cardiovasc Drugs Ther. 24(5-6) ; 379: 389 (2010)

López-Miranda V, Herradón E, Gonzalez C, Martin MI. Vascular toxicity of chemotherapeutic agents. Curr Vasc Pharmacol. 8(5); 692: 700 (2010)

Sánchez EM, Bagüés A, Martín MI. Contributions of peripheral and central opioid receptors to antinociception in rat muscle pain models. Pharmacol, Biochem & Behav. 96(4); 488: 495 (2010)